Dynamic multi-OMICs of glioblastoma reveal sensitivity to neddylation inhibition dependent on nuclear PTEN and DNA replication pathways
S. R. Ferdosi, B. Taylor, M. Lee, S. Peng, N. Tang, R. Bybee, G. Reid, L. Hartmen, K. Garcia-Mansfield, R. Sharma, P. Pirrotte, F. Furnari, H. D. Dhruv, M. E. Berens
Abstract
Withdrawal StatementThe authors have withdrawn their manuscript because the reported synergy of TOP2A inhibitors plus MLN4924 proved to be untrue (not reproducible). Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author (mberens@tgen.org).
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Role of PARylation and PTEN Mutation on PARP and PARG Inhibitor Efficacy on Glioblastoma
H. Hermanowski, B. Huebert, … D. Quenet·bioRxiv·Jun 30, 2020
- Targeting tumour-intrinsic neural vulnerabilities of glioblastoma
S. Lee, T. Weiss, … B. Snijder·bioRxiv·Oct 7, 2022
- PARP inhibitor counteracts Temozolomide Resistance in Glioblastoma Multiforme
Édouard Samarut, Gaston Tabourel, … Aurélien A. Sérandour·bioRxiv·Dec 13, 2024
- PLGA-based dual-loaded nanoformulation of DIM and TMZ - An advanced clinical strategy for brain cancer treatment in a combinatorial approach
S. Sarkar, S. Kumar, … M. K. Ghosh·bioRxiv·May 4, 2023
- Dynamics of repurposing synthetic and natural compounds against WNT/β-Catenin signaling in glioma- An in vivo approach
D. P. S, S. S. Kuduvalli, … A. T. S·bioRxiv·Dec 2, 2022
- MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma
Rajappa S. Kenchappa, László Radnai, … Steven S. Rosenfeld·CellPeer-reviewed·Jun 10, 2025